Development of DNA Microarray for Indication of Viral Community-Acquired Pneumonia Pathogens

The aim of the study is to develop a DNA microarray for the indication of viral pathogens causing community-acquired pneumonia.

Materials and Methods. The study materials were swab samples from the nasopharyngeal and oropharyngeal mucous membranes of patients aged 2 months to 18 years with X-ray confirmed pneumonia. The selection of DNA probes for the specific detection of viral community-acquired pneumonia pathogens and development of the microarray design were carried out using our previously developed disprose program. The nucleotide sequences of pathogens were obtained from the NCBI Nucleotide and GISAID databases. The selected DNA probes were synthesized on CustomArray slides (USA). The optimal hybridization temperature was selected on a model pooled sample containing adenovirus DNA and SARS-CoV-2 coronavirus RNA. The selection criteria were the percentage of effective probes with a standardized hybridization signal (SHS) ≥3 Z and the excess of SHS levels of effective specific probes compared to SHS of effective non-specific probes. The DNA probes were selected for the specific detection of viral community-acquired pneumonia pathogens, characterized by an effective hybridization signal under the identified conditions. Using ROC analysis, threshold values of specific probe signals were established, the excess of which was interpreted as the evidence of the pathogen presence in a sample.

Results. A microarray design included 544 DNA probes for the detection of adenovirus, bocavirus, respiratory syncytial virus, metapneumovirus, parainfluenza virus, rhinovirus, and coronavirus. The DNA probes were synthesized on slides. The optimal DNA hybridization temperature on microarrays was established (47°C). A list of probes for specific detection of adenovirus group B, bocavirus, parainfluenza virus type 3, respiratory syncytial virus, rhinovirus, and SARS-CoV-2 coronavirus, characterized by an effective hybridization signal under the identified conditions, was selected. The threshold values of probe signals for specific detection of these pathogens in clinical samples were determined.

Conclusion. A DNA microarray for the indication of viral community-acquired pneumonia pathogens was developed and synthesized. The interpretation of the hybridization results corresponds to the results obtained by the PCR method. The developed microarray can be used to improve laboratory diagnostics of viral community-acquired pneumonia pathogens.

1. Watkins R.R., Lemonovich T.L. Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician 2011; 83(11): 1299–1306.
2. O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiyskoy Federatsii v 2023 godu: gosudarstvennyy doklad [On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2023: state report]. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare; 2024. URL: https://rospotrebnadzor.ru/upload/iblock/fbc/sd3prfszlc9c2r4xbmsb7o3us38nrvpk/ Gosudarstvennyy-doklad-_O-sostoyanii-sanitarno_ epidemiologicheskogo-blagopoluchiya-naseleniya-v- Rossiyskoy-Federatsii-v-2023-godu_..pdf.
3. Holter J.C., Müller F., Bjørang O., Samdal H.H., Marthinsen J.B., Jenum P.A., Ueland T., Frøland S.S., Aukrust P., Husebye E., Heggelund L. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis 2015; 15: 64, https://doi.org/10.1186/s12879-015-0803-5.
4. Waterer G.W. Diagnosing viral and atypical pathogens in the setting of community-acquired pneumonia. Clin Chest Med 2017; 38(1): 21–28, https://doi.org/10.1016/j.ccm.2016.11.004.
5. Wiemken T.L., Peyrani P., Ramirez J.A. Global changes in the epidemiology of community-acquired pneumonia. Semin Respir Crit Care Med 2012; 33(3): 213–219, https://doi.org/10.1055/s-0032-1315633.
6. Shah B.A., Ahmed W., Dhobi G.N., Shah N.N., Khursheed S.Q., Haq I. Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting. Indian J Chest Dis Allied Sci 2010; 52(1): 9–17.
7. Meyer Sauteur P.M. Childhood community-acquired pneumonia. Eur J Pediatr 2024; 183(3): 1129–1136, https://doi.org/10.1007/s00431-023-05366-6.
8. Jansen R.R., Wieringa J., Koekkoek S.M., Visser C.E., Pajkrt D., Molenkamp R., de Jong M.D., Schinkel J. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 2011; 49(7): 2631–2636, https://doi.org/10.1128/JCM.02094-10.
9. Eads B., Cash A., Bogart K., Costello J., Andrews J. Troubleshooting microarray hybridizations. Methods Enzymol 2006; 411: 34–49, https://doi.org/10.1016/S0076-6879(06)11003-4.
10. Gardner S.N., Jaing C.J., McLoughlin K.S., Slezak T.R. A microbial detection array (MDA) for viral and bacterial detection. BMC Genomics 2010; 11: 668, https://doi.org/10.1186/1471-2164-11-668.
11. Thissen J.B., McLoughlin K., Gardner S., Gu P., Mabery S., Slezak T., Jaing C. Analysis of sensitivity and rapid hybridization of a multiplexed microbial detection microarray. J Virol Methods 2014; 201: 73–78, https://doi.org/10.1016/j.jviromet.2014.01.024.
12. Thissen J.B., Be N.A., McLoughlin K., Gardner S., Rack P.G., Shapero M.H., Rowland R.R.R., Slezak T., Jaing C.J. Axiom microbiome array, the next generation microarray for high-throughput pathogen and microbiome analysis. PLoS One 2019; 14(2): e0212045, https://doi.org/10.1371/journal.pone.0212045.
13. Ferreira I.C.S., Alegretti A.P., De Paris F., Paiva R.M., Chakr V.C.B.G. Comparison of a direct immunofluorescence assay (Oxoid IMAGEN®) and a multiplex RT-PCR DNA microarray assay (CLART® PneumoVir) for the detection of respiratory viruses in hospitalized children. J Virol Methods 2020; 284: 113930, https://doi.org/10.1016/j.jviromet.2020.113930.
14. Filatova E.N., Chaikina A.S., Brusnigina N.F., Makhova M.A., Utkin O.V. An Algorithm for the selection of probes for specific detection of human disease pathogens using the DNA microarray technology. Sovremennye tehnologii v medicine 2022; 14(1): 6–12, https://doi.org/10.17691/stm2022.14.1.01.
15. National Center for Biotechnology Information. Nucleotide. URL: https://www.ncbi.nlm.nih.gov/nucleotide.
16. The GISAID database. URL: https://www.gisaid.org.
17. R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022. URL: https://www.R-project.org.
18. RStudio Team (2020). RStudio: integrated development for R. Boston: RStudio, PBC; 2020. URL: http://www.rstudio.com.
19. Liu R.H., Dill K., Fuji H.S., McShea A. Integrated microfluidic biochips for DNA microarray analysis. Expert Rev Mol Diagn 2006; 6(2): 253–261, https://doi.org/10.1586/14737159.6.2.253.
20. Sakharnov N.A., Filatova E.N., Popkova M.I., Slavin S.L., Utkin O.V. Development of DNA microarray for parallel detection of community-acquired pneumonia bacterial pathogens. Sovremennye tehnologii v medicine 2024; 16(2): 16–26, https://doi.org/10.17691/stm2024.16.2.02.
21. You Y.H., Wang P., Wang Y.H., Wang H.B., Yu D.Z., Hai R., Zhang J.Z. Assessment of comparative genomic hybridization experiment by an in situ synthesized CombiMatrix microarray with Yersinia pestis vaccine strain EV76 DNA. Biomed Environ Sci 2010; 23(5): 384–390, https://doi.org/10.1016/S0895-3988(10)60080-3.
22. Camacho C., Coulouris G., Avagyan V., Ma N., Papadopoulos J., Bealer K., Madden T.L. BLAST+: architecture and applications. BMC Bioinformatics 2009; 10:421, https://doi.org/10.1186/1471-2105-10-421.
23. Raman T., O’Connor T.P., Hackett N.R., Wang W., Harvey B.G., Attiyeh M.A., Dang D.T., Teater M., Crystal R.G. Quality control in microarray assessment of gene expression in human airway epithelium. BMC Genomics 2009; 10: 493, https://doi.org/10.1186/1471-2164-10-493.
24. Ghindilis A.L., Smith M.W., Schwarzkopf K.R., Roth K.M., Peyvan K., Munro S.B., Lodes M.J., Stöver A.G., Bernards K., Dill K., McShea A. CombiMatrix oligonucleotide arrays: genotyping and gene expression assays employing electrochemical detection. Biosens Bioelectron 2007; 22(9-10): 1853–1860, https://doi.org/10.1016/j.bios.2006.06.024.
25. Ashwood B., Jones M.S., Radakovic A., Khanna S., Lee Y., Sachleben J.R., Szostak J.W., Ferguson A.L., Tokmakoff A. Thermodynamics and kinetics of DNA and RNA dinucleotide hybridization to gaps and overhangs. Biophys J 2023; 122(16): 3323–3339, https://doi.org/10.1016/j.bpj.2023.07.009.

Sakharnov N.A., Filatova E.N., Popkova M.I., Lukovnikova L.B., Bahmeteva M.O., Slavin S.L., Utkin O.V. Development of DNA Microarray for Indication of Viral Community-Acquired Pneumonia Pathogens. Sovremennye tehnologii v medicine 2025; 17(3): 17, https://doi.org/10.17691/stm2025.17.3.02